Login

Myovant Sciences Ltd. SEC Filings

Filed On Filing
20 Mar 2023 15-12G
16 Mar 2023 EFFECT
16 Mar 2023 EFFECT
10 Mar 2023 25-NSE
10 Mar 2023 Form 4: Valente Nancy, Director

Returned 3,673 shares to the issuer · Disposed of 36,892 Stock Options (Right to Buy) (Disposition to Issuer)

10 Mar 2023 Form 4: Potter Myrtle S, Director

Returned 3,673 shares to the issuer · Disposed of 146,307 Stock Options (Right to Buy) (Disposition to Issuer)

10 Mar 2023 Form 4: Merendino Lauren, Chief Commercial Officer

Returned 169,538 shares to the issuer · Disposed of 123,300 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 103,703 Performance Stock Unit (Disposition to Issuer)

10 Mar 2023 Form 4: Mehra Uneek, Principal Financial Officer

Returned 202,696 shares to the issuer · Disposed of 165,192 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 111,111 Performance Stock Unit (Disposition to Issuer)

10 Mar 2023 S-8 POS
10 Mar 2023 S-8 POS
10 Mar 2023 S-8 POS
10 Mar 2023 S-8 POS
10 Mar 2023 S-8 POS
10 Mar 2023 S-8 POS
10 Mar 2023 S-8 POS
10 Mar 2023 Form 4: Marek David C, Director

Returned 417,599 shares to the issuer · Disposed of 719,453 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 134,567 Performance Stock Unit (Disposition to Issuer)

10 Mar 2023 SC 13D/A
10 Mar 2023 POS AM
10 Mar 2023 POS AM
10 Mar 2023 Form 4: Lang Matthew, General Counsel & Corp. Secy.

Returned 354,303 shares to the issuer · Disposed of 719,866 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 111,111 Performance Stock Unit (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support